D46.B — Refractory cytopenia with multilineage dysplasia and ring sideroblasts
Is D46.B billable?
Yes — D46.B is billable for FY2027. D46.B is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. D46.B may be submitted for encounters from October 1, 2026 through September 30, 2027.
D46.B at a glance
| Code | D46.B |
|---|---|
| Description | Refractory cytopenia with multilineage dysplasia and ring sideroblasts |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does D46.B group to?
D46.B sits in MDC 16 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 811Red Blood Cell Disorders with MCCmedical
- 812Red Blood Cell Disorders without MCCmedical
How is D46.B listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to D46.B. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Cytopenia › refractory › with multilineage dysplasia › and ring sideroblasts
- Syndrome › myelodysplastic › with › multilineage dysplasia › with ringed sideroblasts
Inclusion terms
Alternative wording in documentation that is classified to D46.B.
- RCMD RS
Excludes1 — never code together — inherited from D37-D48
The conditions below can never be reported together with D46.B on the same claim. An Excludes1 note means the two conditions cannot occur in the same patient, so reporting both is a coding error.
- neoplasms of unspecified behavior (D49.-)
Use additional code — inherited from D46
Report an additional code alongside D46.B to fully describe the condition. D46.B is sequenced first.
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Excludes2 — not included here — inherited from D46
The conditions below are not part of D46.B, but a patient may have both at the same time. When documentation supports it, D46.B and the excluded code may both be reported.
- drug-induced aplastic anemia (D61.1)
How long has D46.B existed?
D46.B has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.
Which conditions are coded to D46.B?
What other codes are in the D46 family? (8)
- D46.0Refractory anemia without ring sideroblasts, so stated
- D46.1Refractory anemia with ring sideroblasts
- D46.2Refractory anemia with excess of blasts [RAEB]not billable
- D46.ARefractory cytopenia with multilineage dysplasia
- D46.CMyelodysplastic syndrome with isolated del(5q) chromosomal abnormality
- D46.4Refractory anemia, unspecified
- D46.ZOther myelodysplastic syndromes
- D46.9Myelodysplastic syndrome, unspecified